Research Progress on the Protective Effect of Green Tea Polyphenol (-)-Epigallocatechin-3-Gallate (EGCG) on the Liver
Nutrients · 21.03.2025 · 17 (7) · 1101
DOI: 10.3390/nu17071101 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 21.03.2025. Verfasst von Fang Zhou und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Environmental Sciences, Xiangnan University, Chenzhou 423000, China. Hauptthemen laut MEDLINE: Catechin, Tea, Liver, Liver Diseases. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 146 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hunan Province natural Science, Achievement Transformation Platform of Xiangnan University-Chenzhou Industrial Technology Research Institute, “Xiao He” Science and technology talent program.
Abstract (Originalsprache)
The liver, as the primary metabolic organ, is susceptible to an array of factors that can harm liver cells and give rise to different liver diseases. Epigallocatechin gallate (EGCG), a natural compound found in green tea, exerts numerous beneficial effects on the human body. Notably, EGCG displays antioxidative, antibacterial, antiviral, anti-inflammatory, and anti-tumor properties. This review specifically highlights the pivotal role of EGCG in liver-related diseases, focusing on viral hepatitis, autoimmune hepatitis, fatty liver disease, and hepatocellular carcinoma. EGCG not only inhibits the entry and replication of hepatitis B and C viruses within hepatocytes, but also mitigates hepatocytic damage caused by hepatitis-induced inflammation. Furthermore, EGCG exhibits significant therapeutic potential against hepatocellular carcinoma. Combinatorial use of EGCG and anti-hepatocellular carcinoma drugs enhances the sensitivity of drug-resistant cancer cells to chemotherapeutic agents, leading to improved therapeutic outcomes. Thus, the combination of EGCG and anti-hepatocellular carcinoma drugs holds promise as an effective approach for treating drug-resistant hepatocellular carcinoma. In conclusion, EGCG possesses hepatoprotective properties against various forms of liver damage and emerges as a potential drug candidate for liver diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemistry and Environmental Sciences, Xiangnan University, Chenzhou 423000, China.
- School of Life and Health Sciences, Hunan University of Science and Technology, Xiangtan 411201, China.
- Key Laboratory of Tea Science of Ministry of Education, Hunan Agricultural University, Changsha 410128, China.
ORCID-Profile: Zhonghua Liu
Förderung
- Hunan Province natural Science
- Achievement Transformation Platform of Xiangnan University-Chenzhou Industrial Technology Research Institute
- “Xiao He” Science and technology talent program
- National Natural Science Foundation of China
- Hunan Provincial Department of Education outstanding youth project
- Provincial Special Project for Construction of Innovation Demonstration Area at Chenzhou City
Zitieren
APA
Zhou, F., Deng, S., Luo, Y., Liu, Z., & Liu, C. (2025). Research Progress on the Protective Effect of Green Tea Polyphenol (-)-Epigallocatechin-3-Gallate (EGCG) on the Liver. Nutrients, 17(7), 1101. https://doi.org/10.3390/nu17071101
Vancouver
Zhou F, Deng S, Luo Y, Liu Z, Liu C. Research Progress on the Protective Effect of Green Tea Polyphenol (-)-Epigallocatechin-3-Gallate (EGCG) on the Liver. Nutrients. 2025;17(7):1101. doi:10.3390/nu17071101
BibTeX
@article{Zhou2025,
author = {Zhou, Fang and Deng, Sengwen and Luo, Yong and Liu, Zhonghua and Liu, Changwei},
title = {Research Progress on the Protective Effect of Green Tea Polyphenol (-)-Epigallocatechin-3-Gallate (EGCG) on the Liver},
journal = {Nutrients},
year = {2025},
volume = {17},
number = {7},
pages = {1101},
doi = {10.3390/nu17071101}
}
EUVIMED